• SENSEX 81,583.30
    -212.85 (--0.26%)
  • BANKNIFTY 55,944.90
    417.55 (+0.75%)
  • Vishal Mega Mart
    129.95 134.50(%)
  • Reliance Industr
    1,425.80 1,115.55(%)
  • Infosys
    1,647.70 2,006.80(%)
  • Sterlite Tech.
    119.00 109.09(%)
  • HDFC Bank
    1,919.55 1,588.50(%)
  • Varun Beverages
    469.50 419.40(%)
  • ICICI Bank
    1,417.60 1,101.00(%)
  • TCS
    3,522.30 4,585.90(%)
  • Happiest Minds
    674.00 955.00(%)
  • Mazagon Dock
    3,342.85 3,778.00(%)
  • Garden Reach Sh.
    3,205.00 3,528.00(%)
  • Bharti Airtel
    1,847.50 1,373.05(%)
  • M & M
    2,993.70 2,360.45(%)
  • Kotak Mah. Bank
    2,129.90 1,679.10(%)
  • Tata Motors
    672.00 542.55(%)
  • Cochin Shipyard
    2,244.10 2,977.10(%)
  • Hind. Unilever
    2,334.10 3,034.50(%)
  • Sun Pharma.Inds.
    1,641.40 1,461.40(%)
  • St Bk of India
    790.75 679.65(%)
  • HCL Technologies
    1,738.00 2,011.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Natural Capsules Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 4124.0
  • ISIN : INE936B01015
223.81 -6 (-2.78%)
  • As on 17 Jun 2025 (EOD)
  • Today’s Low

    223.01
  • Today’s High

    231.98
  • Open

    231.98
  • Perv Close

    230.22
  • 52W Low

    164.00
  • 52W High

    274.75

Key Indicators

  • P/E(TTM)

    34.29

  • Mar.Cap (₹Cr.)

    231.45

  • Div & Yield %

    0.00

  • Book Value(₹)

    160.83

  • Debt-Equity Ratio

    -2.78

  • AGM Date

    16-Jun-2025

  • EPS

    6.49

  • P/E Ratio

    34.29

Financials Ratios

  • Debt-Equity Ratio

    0.63

  • Mar.Cap (₹Cr.)

    231.45

  • RONW (%)

    3.39

  • ROCE (%)

    5.00

Score Board

  • Equity (₹ in Cr.)

    10.34

  • BV (₹)

    160.80

  • Sales( ₹ in Cr.)

    167.94

  • NP (in Cr.)

    6.71

  • NP Var(%)

    -14.0

  • Div%

    0.0

  • CPS (₹)

    14.50

  • EPS (₹)

    6.50

  • Traded Value (₹ in Lakhs)

    230.14

  • 52 Week High

    274.75

  • 52 Week Low

    164.00

  • Price BSE

    223.0

  • Price NSE

    224.00

  • Market Capital( in Cr.)

    230.14

  • P/C Ratio

    15.30

  • P/E Ratio

    34.40

  • Price Vs.BV

    6.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 153.81 172.87 135.07 79.51 61.55 59.78
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 153.81 172.87 135.07 79.51 61.55 59.78
Other Income 3.15 1.07 0.93 2.90 0.95 1.14
Stock Adjustments 6.13 5.18 -1.81 -1.33 -0.11 -3.69
Total Income 163.09 179.12 134.19 81.08 62.39 57.23
EXPENDITURE :            
Raw Materials 83.32 84.14 57.99 36.10 27.92 22.80
Power and Fuel Cost 15.19 13.75 11.90 8.51 8.16 8.89
Employee Cost 10.95 9.51 8.48 6.97 5.91 5.57
Other Manufacturing Expenses 12.58 11.79 7.57 4.45 4.53 4.59
Selling and Administration Expenses 17.20 22.86 16.87 9.73 8.99 8.89
Miscellaneous Expenses -0.20 0.24 4.83 1.29 0.49 0.69
Employee Benefit Expenses 10.95 9.51 8.48 6.97 5.91 5.57
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 139.04 142.30 107.64 67.05 56.00 51.43
Operating Profit 24.05 36.82 26.54 14.04 6.40 5.80
Interest 5.09 3.88 2.08 0.54 0.91 0.53
Gross Profit 18.96 32.94 24.46 13.50 5.49 5.27
Depreciation 8.57 7.20 5.04 4.31 4.12 3.20
Profit Before Tax 10.39 25.74 19.42 9.19 1.37 2.07
Current Tax 1.97 5.46 4.74 2.22 0.66 0.79
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.62 1.09 0.73 0.02 -0.14 -0.65
Reported Net Profit 7.81 19.20 13.95 6.95 0.86 1.92
Extraordinary Items 0.00 0.03 0.05 1.65 0.00 -0.22
Adjusted Net Profit 7.81 19.17 13.90 5.30 0.86 2.14
Adjustment below Net Profit 0.00 0.00 -0.20 -0.06 -0.11 -0.13
P & L Balance brought forward 74.29 55.86 42.73 36.22 36.09 34.92
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.93 0.77 0.62 0.37 0.62 0.62
P & L Balance carried down 81.16 74.29 55.86 42.73 36.22 36.09
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 10.00 10.00 10.00 6.00 10.00
Dividend Per Share(Rs) 0.00 1.00 1.00 1.00 0.60 1.00
Earnings Per Share-Unit Curr 8.36 20.70 19.90 11.15 1.38 3.08
Earnings Per Share(Adj)-Unit Curr 8.36 20.70 19.90 9.14 1.13 2.53
Book Value 141.30 133.74 118.45 99.68 89.24 89.04
Book Value(Adj)-Unit Curr 141.30 133.74 118.45 81.74 73.18 73.01

Shareholding Pattern

  • Promoter Group

    51.21%

  • Public Share Holding

    48.79%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 2,172,854 21.01 2,172,854 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 2,261 0.02 1,861 5
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,120,633 30.18 3,120,633 12
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,295,748 51.21 5,295,348 19
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 1,032,855 9.99 1,031,455 68
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 156,675 1.52 151,075 153
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 150,000 1.45 150,000 1
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 846,477 8.19 846,477 12
Individuals holding nominal share capital up to Rs. 1 lakh 2,575,294 24.90 2,477,669 8,966
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 284,105 2.75 284,105 206
Sub Total 5,045,406 48.79 4,940,781 9,406
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 10,341,154 100.00 10,236,129 9,425

Company Background

Natural Capsules LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Natural Capsules Ltd
  • BSE Code : 4124.0
  • ISIN : INE936B01015
  • Incorporation Year

    1993

  • Registered Office

    Trident Towers 4th Floor No 23
    100Feet Road Jayanagar IIBlock, Bangalore,
    Karnataka-560011

  • Telephone

    91-080-26671571/26671573/26671581

  • FAX

    91-080-26671562

  • Chairman

    C P Rangachar

  • Managing Director

    Sunil L Mundra

  • Company Secretary

  • Auditor

    P Chandrasekar LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Cameo Corporate Services Ltd
    Subramanian Building,
    1ST Floor No 1,Club House Road
    Mumbai - Chennai - 600002

Natural Capsules Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Natural Capsules 222.55 156.95 153.81 34.29 8.43
Abbott India 31,658.15 6,097.18 5,848.91 47.56 44.71
Astrazeneca Phar 10,204.20 1,330.33 1,295.53 220.39 33.26
P & G Health Ltd 5,907.60 1,166.89 1,151.26 39.04 39.76
Glaxosmi. Pharma 3,366.50 3,866.05 3,723.49 62.06 58.72
Cipla 1,526.90 17,645.00 16,574.34 23.91 20.10
Amrutanjan Healt 700.10 437.58 421.23 39.82 20.84
Guj. Themis Bio. 349.55 174.19 169.82 78.02 44.82
Fermenta Biotec. 341.00 315.24 307.09 14.85 4.10
Bliss GVS Pharma 147.30 638.96 605.46 22.49 11.19
Ambalal Sarabhai 36.91 11.70 3.81 34.18 1.92